Sanofi (SNY) Exchange Rate Effect (2013 - 2026)
Sanofi's (SNY) quarterly Exchange Rate Effect came in at $10.5 million in Q1 2026, up 150.08% year-on-year from $4.2 million in Q1 2025, and up 119.26% quarter-over-quarter from -$54.7 million in Q4 2025.
Sanofi (SNY) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Sanofi has disclosed Exchange Rate Effect across 4 years of filings, most recently posting $10.5 million for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $10.5 million, up 150.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$132.2 million (down 169.94% YoY), and the FY2025 annual result was -$54.7 million, down 293.83% from the prior year.
- Exchange Rate Effect came in at $10.5 million for Q1 2026 at Sanofi, up from -$54.7 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $10.5 million in Q1 2026 to a low of -$63.1 million in Q3 2025.
- The 3-year median for Exchange Rate Effect is -$17.5 million (2024), against an average of -$22.6 million.
- Across the five-year window, Exchange Rate Effect plunged 293.83% in 2025 and soared 150.08% in 2026, its largest moves.
- Sanofi's Exchange Rate Effect stood at -$13.9 million in 2024, then slumped by 293.83% to -$54.7 million in 2025, then jumped by 119.26% to $10.5 million in 2026.
- The last three Exchange Rate Effect figures came in at $10.5 million (Q1 2026), -$54.7 million (Q4 2025), and -$63.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 2.70 Mn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 67.00 Mn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | -25.00 Mn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | -12.00 Mn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | -19.00 Mn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | -11.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 19.00 Mn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | -48.00 Mn |
| 10 | Sanofi | 63.47 Mn | -6.87 Bn | 9.49 Bn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.54 Mn |
| Mar 31, 2026 | 10.54 Mn |
| Dec 31, 2025 | -54.71 Mn |
| Dec 31, 2025 | -54.71 Mn |
| Sep 30, 2025 | -63.13 Mn |
| Sep 30, 2025 | -63.13 Mn |
| Jun 30, 2025 | -24.90 Mn |
| Jun 30, 2025 | -24.90 Mn |
| Mar 31, 2025 | -21.04 Mn |
| Mar 31, 2025 | -21.04 Mn |
| Dec 31, 2024 | -13.89 Mn |
| Dec 31, 2024 | -13.89 Mn |
| Jun 30, 2024 | -8.62 Mn |
| Jun 30, 2024 | -8.62 Mn |
| Mar 31, 2024 | -5.43 Mn |
| Mar 31, 2024 | -5.43 Mn |
| Jun 30, 2013 | -58.76 Mn |
| Jun 30, 2013 | -58.76 Mn |